Application

PTO- 1478

Approved for use through 04/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 04/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90647623

Filing Date: 04/15/2021

To the Commissioner for Trademarks:

MARK: TRANSLATE THERAPEUTICS (Standard Characters, see below )

The literal element of the mark consists of TRANSLATE THERAPEUTICS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Translate Bio, Inc., a corporation of Delaware, having an address of
      29 Hartwell Avenue
      Lexington, Massachusetts 02421
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Medical and scientific research
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Christina M. Licursi. Other appointed attorneys are Michael A. Albert, Nicole Davis Amar, Eric L. Amundsen, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Joshua M. Brandt, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Bryan S. Conley, Gregory F. Corbett, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Emily J. Gardel, Edward R. Gates, David S. Gesner, Richard F. Giunta, Matthew H. Grady, Patricia L. Granahan, Michael A. Greene, Eric P. Greenwald, Philip J. Hamzik, James M. Hanifin, Jr., John S. Harmon, , Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Hunter D. Keeton, Jessamine M. Lee, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Kevin MacDonald, Robert T. Maldonado, Ethan W. Marks, Kira-Khanh McCarthy, William R. McClellan, Gabriel J. McCool, Marie A. McKiernan, Anshul M. Mehra, Andrea D. Merin, Kevin Mosier, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Zachary P. Piccolomini, Michael J. Pomianek, Randy J. Pritzker, Michael N. Rader, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia Sayour, Claire E. Schuster, Karan Singh, Amanda Slade, Laura B. Sole, Nathan R. Speed, Charles T. Steenburg, John L. Strand, Shirley Tan, Andrew J. Tibbetts, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Daniel T. Wehner, John L. Welch, Andrew W. Williams, Douglas R. Wolf, Daniel W. Young, Lock See Yu-Jahnes, William Wei Zhang, Chelsea E. Witte-Garcia, Adam Z. Zeiger, Norman H. Zivin. Christina M. Licursi of Wolf, Greenfield & Sacks, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      600 Atlantic Avenue
      Boston, Massachusetts 02210
      United States
      617-646-8000(phone)
      617-646-8646(fax)
      cxltrademarks@wolfgreenfield.com
The docket/reference number is R06932000201.
Christina M. Licursi submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Christina M. Licursi

PRIMARY EMAIL FOR CORRESPONDENCE: cxltrademarks@wolfgreenfield.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature
The attached signature image file:
\\TICRS\EXPORT18\IMAGEOUT18\906\476\90647623\xml1\APP0003.JPG



Signatory's Name: Sharon Walker
Signatory's Position: Director, Legal
Signatory's Phone Number: Not Provided
Signature method: Handwritten
Payment Sale Number: 90647623
Payment Accounting Date: 04/15/2021

Serial Number: 90647623
Internet Transmission Date: Thu Apr 15 12:40:54 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2021041512405427
0026-90647623-770b934a2312314e652dba2456
f320bec7d07fd9e3cff424e37e49e1cca3040a9-
CC-40522596-20210415121222300978